美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Faeth Therapeutics

37.44

-1.5600-4.00%

盤後：37.440.00000.00%19:30 EDT

成交量：37.71萬

成交額：1,433.86萬

市值：9.65億

市盈率：-0.26

高：40.50

開：39.08

低：36.31

收：39.00

52周最高：42.14

52周最低：7.45

股本：2,577.88萬

流通股本：81.17萬

量比：1.39

換手率：46.46%

股息：- -

股息率：- -

每股收益(TTM):-141.6499

每股收益(LYR):-16.7239

淨資產收益率：-195.26%

總資產收益率：-20.79%

市淨率：5.58

市盈率(LYR):-2.24

資料載入中...

總覽公司新聞公告

FDA授予抗癌藥物快速通道資格後，Faeth Therapeutics股價上漲

Faeth Therapeutics：晚期子宮內膜癌2期試驗頂線數據預計2026年底公布

美國研究綜述-美國鐵塔公司、H.B.富勒公司、TD Synnex

Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布

Sensei Biotherapeutics：Piktor治療晚期子宮內膜癌的II期關鍵數據預計2026年下半年公布

Sensei Biotherapeutics任命Anand Parikh為董事長、總裁兼首席執行官，自2026年6月12日起生效

Sensei Biotherapeutics更名為Faeth Therapeutics，全力推進口服抗癌療法Piktor

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/FTH/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":37.44,"timestamp":1789156800000,"preClose":39,"halted":0,"volume":377119,"hourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:30 EDT","volume":929,"amount":34772.58,"timestamp":1789169405030,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.040000000000000056,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"休市中","change":-1.56,"latestTime":"09-11 16:00:00 EDT","open":39.08,"high":40.5,"low":36.31,"amount":14338626.28731,"amplitude":0.107436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":39,"preHourTrading":{"tag":"盘前","latestPrice":39.01,"preClose":39,"latestTime":"07:00 EDT","volume":20,"amount":780.1999999999999,"timestamp":1789124400227,"change":0.01,"changeRate":0.000256,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:30 EDT","volume":929,"amount":34772.58,"timestamp":1789169405030,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3880703379495405},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.3880703379495405,"shares":25778800,"dividePrice":0,"high":40.5,"amplitude":0.107436,"preClose":39,"low":36.31,"week52Low":7.45,"pbRate":"5.58","week52High":42.1431,"institutionHeld":0,"latestPrice":37.44,"eps":-141.6499,"divideRate":0,"volume":377119,"delay":0,"ttmEps":-141.6499,"open":39.08,"prevYearClose":10.67,"prevWeekClose":40.05,"prevMonthClose":32.77,"prevQuarterClose":25,"fiveDayClose":39,"twentyDayClose":28.55,"sixtyDayClose":14.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-11","current":-0.264314,"percent":0.051724,"low":-5.292894,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"high":-0.105707,"avg":-3.808203,"sd":1.140923,"marketCap":1007776575},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575}],"updateTime":1789272812107},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660448760","title":"FDA授予抗癌藥物快速通道資格後，Faeth Therapeutics股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448760","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448760?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:19","pubTimestamp":1786969153,"startTime":"0","endTime":"0","summary":"BUZZ-FDA授予抗癌药物快速通道资格后，Faeth Therapeutics股价上涨8月17日-** 抗癌药物开发商 Faeth Therapeutics（FTH.O）的股价在盘前交易中上涨 2%，至 33 美元** 该公司表示，美国食品药品监督管理局（FDA）已授予其实验性双药疗法PIKTOR（联合化疗）快速通道资格，该疗法适用于部分晚期或复发性子宫内膜癌患者，子宫内膜癌是一种起源于子宫内膜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137671951","title":"Faeth Therapeutics：晚期子宮內膜癌2期試驗頂線數據預計2026年底公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1137671951","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137671951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:33","pubTimestamp":1786966420,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics宣布，其针对晚期子宫内膜癌的2期临床试验顶线数据，预计将于2026年底揭晓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646343783","title":"美國研究綜述-美國鐵塔公司、H.B.富勒公司、TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646343783","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646343783?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 15:07","pubTimestamp":1782457653,"startTime":"0","endTime":"0","summary":"美国研究综述-美国铁塔公司、H.B.富勒公司、TD Synnex路透6月26日-周五，华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价，其中包括美国铁塔公司、H.B.富勒公司和TD Synnex。重点摘要* 美国铁塔公司AMT.N：加拿大皇家银行将其评级从“行业表现”上调至“跑赢大盘”* H.B.富勒公司 FUL.N：摩根大通将评级从“中性”上调至“超配”* TD SynnexSNX.N：RBC将目标价从315美元上调至340美元以下是路透周五报导的针对美国公司的研究动向摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4T42Y0EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU1221951046.USD","BK4177","LU2089284900.SGD","LU1228905037.USD","LU0444973449.USD","LU0124676726.USD","LU0792757196.USD","LU1066051225.USD","LU1280957306.USD","FTH","LU0345770308.USD","BK4559","LU2357627491.SGD","LU1244550221.USD","LU2403377893.USD","BK4501","SG9999002224.SGD","IE00BFMHRM44.USD","LU0175139822.USD","LU1868836757.USD","LU1917777945.USD","LU0724618433.USD","LU0957808578.USD","AMAT","IE00BGHQF631.EUR","LU0882574055.USD","LU1046421795.USD","LU1261432733.SGD","ON","BK4209","LU0957791311.USD","LMTL","LU0096364046.USD","LU1121112475.USD","LU0354030511.USD","LU0231203729.USD","BK4592","LU1732799900.SGD","IE00B19Z3581.USD","LU1868836591.USD","IE00B3PB1722.GBP","SG9999001176.USD","IE00BKVL7J92.USD","LU0943347566.SGD","LU0708995666.HKD","LU0795875086.SGD","LU0256331488.USD","LU0127658192.USD","LU2129689605.HKD","BK4147","SG9999013999.USD","LMT","LU1032955483.USD","LU1551013425.SGD","IE000BZT7R73.USD","BK4543","LU1043141123.HKD","LU0821914370.USD","LU0098860793.USD","SYNA","LU1228905540.USD","LU0949170772.SGD","LU0289739699.SGD","LU1162221912.USD","LU2211815571.USD","BK4516","LU1989763005.USD","LU2506952097.USD","BK4532","IE00BLSP4452.SGD","IE0001KFT4U8.USD","IE00BQXX3F31.USD","LU0820561909.HKD","LU0124384867.USD","LU1935042991.SGD","LU0072462343.USD","LU1983260115.SGD","LU1048596156.SGD","LU0097036916.USD","PCTY","LU0689626769.HKD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","IE00B5949003.HKD","LU0109392836.USD","LU1868837300.USD","LU0444971666.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU2413666699.HKD","SNX","LU2111349929.HKD","LU1629891620.HKD","IE000M9KFDE8.USD","BK4566","LU2506951875.HKD","LU1720051108.HKD","LU1718418525.SGD","AMT","LU1894683264.USD","IE0009356076.USD","IE00BBT3K403.USD","BK4553","LU0061474960.USD","LU2756315318.SGD","LU0287143357.SGD","LU0154236417.USD","LU1642822529.SGD","LU0823417737.USD","LU0545039389.USD","BK4504","LU2023250843.SGD","LU2023251221.USD","LU2236285917.USD","LU2505996509.AUD","LU1059921491.USD","MU","SG9999001176.SGD","04336","IE00BD6J9T35.USD","JNJ","BK4219","LU1069344957.HKD","LU1861215975.USD","LU1868836914.USD","LU2129689514.USD","LU2931357623.SGD","LU2458330243.SGD","LU1721428933.USD","BK4023","LU1720051017.SGD","LU2471134952.CNY","LU1221951129.SGD","LU1861219969.SGD","LU2286300806.USD","LU0702159343.USD","LU1061106388.HKD","LU2089985449.USD","LU1244550494.USD","LU0154245756.USD","BK4534","BK4134","LU1929549753.HKD","SG9999002232.USD","MULL","LU0058720904.USD","LU1166156734.SGD","LU0198837287.USD","LU1323610961.USD","LU0114720955.EUR","LU0345770993.USD","LU2087621335.USD","LU1496350502.SGD","KWR","LU0345769631.USD","LU2054465674.USD","LU0158827948.USD","LU0011850046.USD","LMTS","DRI","PEP","BK4579","BK4140","LU1674673428.USD","BK4575","IE00BSNM7G36.USD","MRNX","LU0122379950.USD","BK4564","LU2506952170.USD","LU0056508442.USD","LU2089283258.USD","LU0823417653.USD","LU1823568750.SGD","LU1868837136.USD","LU2592432038.USD","LU1815336091.USD","LU0868494708.USD","LU0795875169.SGD","BK4139","LU0320765646.SGD","BK4597","CTSH","LU0432979614.USD","IE00BJJMRZ35.SGD","LU2360107168.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0203345920.USD","MUU","SG9999001440.SGD","BK4585","LU0234572021.USD","LU0210536198.USD","LU2543165471.USD","LU2417539215.USD","BK4084","LU0820561818.USD","LU1153585028.USD","LU0197229882.USD","LU0950375773.USD","LU2506951958.HKD","LU0354030438.USD","IE00BVYPNV92.GBP","INR","LU1066051498.USD","IE0000B7K699.USD","LU1057294990.SGD","LU1815333072.USD","LU1914381329.SGD","IE00BJT1NW94.SGD","BK4604","LU0053666078.USD","LU1894683348.USD","LU2133065610.SGD","LU0787776722.HKD","LU2360107325.USD","LU0689472784.USD","LU1989773731.SGD","BK4603","LU2750360997.AUD","LU1506573853.SGD","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","LU2471134796.USD","IE00B7SZLL34.SGD","LU2413666426.HKD","LU2089984988.USD","BK4130","BK4141","BK4215","LU0061475181.USD","IE000SO60NU8.SGD","LU0553294199.USD","IE00B19Z3B42.SGD","LU0081259029.USD","LU0238689110.USD","LU0889566641.SGD","LU2357305700.SGD","LU0289960550.SGD","BK4533","BK4109","LU2750360641.GBP","LU1316542783.SGD","LU2430703095.HKD","LU0157215616.USD","LU1023059063.AUD","IE000WAW04H5.SGD","LU2602419157.SGD","IE0002270589.USD","IE00B3T34201.USD","BK4518","LU2430703178.SGD","LU0642271901.SGD","IE000F7OJYX1.SGD","LU0070217475.USD","ESS","LU1732800096.USD","SG9999001424.SGD","IE00BFXG1179.USD","LU0426417589.USD","LU0154245673.USD","IE0034390439.USD","LU1852331112.SGD","LU1267930813.SGD","LU0719512351.SGD","LU1145028129.USD","OVV","BK4527","LU1430594728.SGD","GB00BDT5M118.USD","LU2129689431.USD","LU0203347892.USD","LU2250418816.HKD","BK4567","LU0079474960.USD","BK4551","LU0096362180.USD","LU2112291526.USD","SG9999000418.SGD","LU1674673691.USD","LU0082616367.USD","LU0820562030.AUD","BK4007","LU0994945656.USD","AR","BK4213","BK4187","LU2347655156.SGD","LU1032466523.USD","LU2360106780.USD","BK4605","BK4519","LU1861220033.SGD","AVXX","LU1983299246.USD","LU0006061336.USD","LU0683600562.USD","LU0702159699.USD","LU2298322129.HKD","LU2106854487.HKD","LU0912757837.SGD","LU1854103824.USD","BK4550","LU1035775433.USD","LU1366333091.USD","LU0964807845.USD","LU1805238398.USD","LU1854104046.USD","IE0009355771.USD","SGXZ57979304.SGD","LU0661504455.SGD","LU2471134879.HKD","IE00BQXX3D17.EUR","LU1861214812.USD","LU1066053197.SGD","LU0426412945.USD","BK4548","LU0210528500.USD","LU1196500208.SGD","MRNA","IE00BLSP4239.USD","LU0466842654.USD","LU2290526834.HKD","LU1048588211.SGD","LU0757428866.USD","LU2213496289.HKD","LU1066051811.HKD","LU0985320562.USD","FUL","LU0889565833.HKD","IE00B19Z6F94.USD","KYMR","LU1815336760.USD","BK4554","BK4588","LU2028103732.USD","LU2048586759.USD","LU1585245621.USD","BK4512","LU0345769128.USD","LU1267930656.SGD","IE00BVYPNW00.USD","LU0640476718.USD","LU0545562505.USD","LU0738911758.USD","MUD","AVAV","LU1043141396.HKD","LU2505996681.GBP","LU2756315664.SGD","LU2468319806.SGD","LU1074936037.SGD","IE00BQXX3C00.GBP","IE00BK4W5L77.USD","LU1974910355.USD","BK4581","IE0002141913.USD","IE0034235303.USD","LU2430703251.USD","LU1839511570.USD","LU0274383776.USD","LU0536402901.SGD","LU2023250330.USD","LU0347712357.USD","LU1551013342.USD","LU0234570918.USD","IE00B42XCP33.USD","LU2487616109.SGD","LU0158827781.USD","LU1778281490.HKD","IE00B2B36J28.USD","LU1978683503.SGD","LU2896262040.SGD","LU2271345857.HKD","LU1244550577.SGD","BK4568","LU1003077747.HKD","LU0476273544.USD","LU0942090050.USD","LU2471134523.USD","LU0859254822.USD","LU2456880835.USD","LU2458330169.SGD","IE00B4R5TH58.HKD","LU1548497426.USD","MRNY","LU0348723411.USD","IE00BZ199S13.USD","LU1803068979.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155638133","title":"Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155638133?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据，预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197135575","title":"Sensei Biotherapeutics：Piktor治療晚期子宮內膜癌的II期關鍵數據預計2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197135575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197135575?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选药物Piktor针对晚期子宫内膜癌的II期临床试验关键性数据，预计将于2026年下半年公布。这一时间表为关注该疗法进展的投资者和医学界提供了明确的时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110665123","title":"Sensei Biotherapeutics任命Anand Parikh為董事長、總裁兼首席執行官，自2026年6月12日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110665123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110665123?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:11","pubTimestamp":1781525508,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. (SNSE) 宣布，自2026年6月12日起，Anand Parikh将正式出任公司董事长、总裁兼首席执行官。此项任命标志着公司领导层的重要更迭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139331227","title":"Sensei Biotherapeutics更名為Faeth Therapeutics，全力推進口服抗癌療法Piktor","url":"https://stock-news.laohu8.com/highlight/detail?id=1139331227","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139331227?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:10","pubTimestamp":1781525426,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. 宣布将公司名称变更为Faeth Therapeutics。这一更名标志着公司战略重心聚焦于推进其核心候选药物Piktor的研发。Piktor是一种口服疗法，旨在靶向癌症中最常发生异常改变的信号通路之一。公司此举旨在更好地反映其专注于开发变革性癌症治疗药物的新方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}